Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study on LITT for Medical Refractory Epilepsy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Relevant Inclusion Criteria are listed below~* Diagnosis of unilateral medial temporal lobe epilepsy (MTLE) confirmed clinically and with either (1) ictal scalp recording and MRI evidence of mesial temporal sclerosis or (2) intracranial ictal onset consistent with hippocampal origin~* Averages 1 or more complex partial seizures or secondary generalized seizures compatible with MTLE per month~* On stable antiepileptic medications~* Meets the criteria for a medial temporal lobe resection and is a candidate for LITT~* 18 years or older at the time of consent~Relevant Exclusion Criteria are listed below~* Previous diagnosis of psychogenic/non-epileptic seizures~* Previous diagnosis of primary generalized seizures~* IQ less than 70~* Subject has a MRI-incompatible implanted electronic device or any metallic prosthesis or implant for which brain MRI is contraindicated

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- NeuroBlate LITT Treatment (Type: OTHER): This is a single arm study. All eligible study subjects will undergo LITT with the NeuroBlate System.

Based on this trial design, predict the completion outcome and termination type (if applicable).